Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$18,000.00

VR-planSys: towards a viable 3D surgical planning system for treating lung cancer

FY 2010-11

Summary
Surgical removal of lung cancer is the treatment of choice. Detailed anatomic information, acquired via surgical planning by reading computed tomographic (CT) images, is crucial to precisely determine whether a cancer lesion is removable and how a surgical procedure preserves maximal lung function. Modern multi-slice CT scanners have severely taxed the surgeon's ability to handle all information - imagine the workload of reading about 800 CT images of a lung cavity and mapping anatomic structures from them onto the actual lung cavity in three dimensions! The current clinical practice is to compress multiple high-resolution CT images (typically 0.6 mm thickness) into one standard CT image of 2.5 - 5.0 mm thickness. This compression results in the loss of detailed and valuable information and, in principle, should be used for better patient care. Surgical planning based on standard CT images also causes about 10% of patients undergoing invasive procedures only to discover that their lung cancer is not removable. Based on advanced virtual reality (VR) technologies, our long-term objective is to create VR-planSys - the world's first 3D VR surgical planning system for treating lung cancer. To fit into an office, VR-planSys will be a self-contained desktop VR system and generate 3D stereoscopic displays of lung cavities from high-resolution CT images. Underpinning VR-planSys will be advanced haptics (simulating the sense of touch) to enhance intuitive interaction with the 3D displays. Our short-term objectives are to develop: (a) viable segmentation algorithms to automatically extract all anatomic structures from high-resolution CT images of lung cavities; and (b) intuitive human-computer interfaces to correctly integrate visual and haptic information without perceptual illusions. Our feasibility work confirms that VR-planSys is achievable using current technologies and knowledge. The initial results demonstrate that viewing 3D displays of lung cavities has significant advantages over reading standard CT images for surgical planning. VR-planSys will improve patient care; facilitate the development of new surgical procedures; and bridge VR-based surgical planning and simulation for treating other diseases.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
312554-2008
Name nom
Hu, Yaoping
Department département
Electrical and Computer Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
18000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
335
Committee name en
Electromag. & Electr. Systems (H)
Committee name fr
Électromagn. et syst. électr. (H)
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
3
Nb partie
5
Application title
VR-planSys: towards a viable 3D surgical planning system for treating lung cancer
Keyword
NSERC
Application summary
Surgical removal of lung cancer is the treatment of choice. Detailed anatomic information, acquired via surgical planning by reading computed tomographic (CT) images, is crucial to precisely determine whether a cancer lesion is removable and how a surgical procedure preserves maximal lung function. Modern multi-slice CT scanners have severely taxed the surgeon's ability to handle all information - imagine the workload of reading about 800 CT images of a lung cavity and mapping anatomic structures from them onto the actual lung cavity in three dimensions! The current clinical practice is to compress multiple high-resolution CT images (typically 0.6 mm thickness) into one standard CT image of 2.5 - 5.0 mm thickness. This compression results in the loss of detailed and valuable information and, in principle, should be used for better patient care. Surgical planning based on standard CT images also causes about 10% of patients undergoing invasive procedures only to discover that their lung cancer is not removable. Based on advanced virtual reality (VR) technologies, our long-term objective is to create VR-planSys - the world's first 3D VR surgical planning system for treating lung cancer. To fit into an office, VR-planSys will be a self-contained desktop VR system and generate 3D stereoscopic displays of lung cavities from high-resolution CT images. Underpinning VR-planSys will be advanced haptics (simulating the sense of touch) to enhance intuitive interaction with the 3D displays. Our short-term objectives are to develop: (a) viable segmentation algorithms to automatically extract all anatomic structures from high-resolution CT images of lung cavities; and (b) intuitive human-computer interfaces to correctly integrate visual and haptic information without perceptual illusions. Our feasibility work confirms that VR-planSys is achievable using current technologies and knowledge. The initial results demonstrate that viewing 3D displays of lung cavities has significant advantages over reading standard CT images for surgical planning. VR-planSys will improve patient care; facilitate the development of new surgical procedures; and bridge VR-based surgical planning and simulation for treating other diseases.